FDA Adverse Event Injury Summary report: N

TRILOGY ACETABULAR SYSTEM LINER

MDR report key: 1060445 · Received June 13, 2008

Report

Report Number
1822565-2008-00312
Event Type
Injury
Date Received
June 13, 2008
Date of Event
February 12, 2007
Report Date
May 16, 2008
Manufacturer
ZIMMER, INC.
Product Code
KWB
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE WAS IN-VIVO FOR APPROXIMATELY 137 MONTHS. DEVICES AND POST SURGERY X-RAYS ARE NOT AVAILABLE FOR REVIEW. SURGERY DETAILS OF HOW THE LINER WAS ASSEMBLED ARE NOT AVAILABLE. LINER WEAR PERFORMANCE/DEGRADATION OF A COMPONENT IS DEPENDENT ON MANY FACTORS, INCLUDING PT ACTIVITY AND PT WEIGHT, MANY OF WHICH ARE OUT OF THE CONTROL OF THE MFR. THE COMPONENT IN QUESTION WAS PROPERLY MANUFACTURED FROM APPROVED MATERIALS IN ACCORDANCE WITH THE MANUFACTURING PRACTICES OF THE TIME. DETAILS LIKE BODY WEIGHT DURING IMPLANT AND EXPLANT, ACTIVITY LEVEL, BUILD, AND SEX ARE NOT AVAILABLE FOR CURRENT CASE. SINCE THE POLY-LINER WAS NOT SENT FOR REVIEW, IN-HOUSE STUDY COULD NOT BE PERFORMED. CAUSE CANNOT BE DEFINITIVELY DETERMINED. NO PRODUCT WAS RETURNED. REVIEW OF THE DEVICE HISTORY RECORDS DID NOT FIND ANY DEVIATIONS OR ANOMALIES. IT IS NOT SUSPECTED THAT THE PRODUCT FAILED TO MEET SPECIFICATIONS. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY EVIDENCE OF PRODUCT CONTRIBUTION TO THE REPORTED PROBLEM. BASED ON THE INVESTIGATION, THE NEED FOR CORRECTIVE ACTION IS NOT INDICATED. SHOULD ADDITIONAL SUBSTANTIVE INFO BE REC'D, THE COMPLAINT WILL BE REOPENED. ZIMMER CONSIDERS THE INVESTIGATION CLOSED.

Description of Event or Problem · 1

IT IS REPORTED THAT THE DEVICE WAS IMPLANTED IN 1995. THE DEVICE WAS REVISED IN 2007, DUE TO DISLOCATION, LINER WEAR, AND MILD ACETABULAR OSTEOLYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TRILOGY ACETABULAR SYSTEM LINER HIP PROSTHESIS KWB ZIMMER, INC. NA 52167200

Patients

Seq Age Sex Outcome Treatment
1 UNK Hospitalization| R